Enlivex Therapeutics Ltd. Analysis
| Analyst Ratings |
|
Average Target Price
|
15.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.36
|
0.00
|
0.36
|
100.00%
|
|
2022-09-30
|
-0.29
|
-0.31
|
-0.02
|
-6.90%
|
|
2022-06-30
|
-0.45
|
-0.54
|
-0.09
|
-20.00%
|
|
2022-03-31
|
-0.28
|
-0.45
|
-0.17
|
-60.71%
|
|
2021-09-30
|
-0.21
|
-0.19
|
0.02
|
9.52%
|
|
2021-06-30
|
-0.26
|
-0.17
|
0.09
|
34.62%
|
|
2021-03-31
|
-0.25
|
-0.43
|
-0.18
|
-72.00%
|
|
2020-12-31
|
-0.24
|
-0.25
|
-0.01
|
-4.17%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-09-30
|
-2.09
|
|
2020-12-31
|
-0.92
|
|
2019-12-31
|
-0.81
|
|
2018-12-31
|
-3.12
|
|
2017-12-31
|
-13.12
|
|
2016-12-31
|
-21.50
|
|
2015-12-31
|
-1.08
|
|
2014-12-31
|
-4.42
|